What Does Maternal Cell Contamination Mean

By Bella Sungkawa | Published: | Updated: | Health and Wellness | 2 min read

Short Answer

Maternal cell contamination (MCC) is the presence of a mother's cells in a fetal sample used for genetic testing. It can interfere with prenatal diagnoses and is detected through specialized laboratory methods.

Complete Explanation

Maternal cell contamination (MCC) refers to the presence of maternal cells in a biological sample that is intended to represent fetal tissue, such as amniotic fluid, chorionic villi, or fetal blood. MCC can arise during specimen collection, processing, or storage, and it may lead to inaccurate genetic or chromosomal results if not identified and corrected.

  • Typical sources:
    Maternal epithelial cells, leukocytes, or decidual tissue that inadvertently mix with the fetal specimen during invasive procedures.
  • Impact on testing:
    Contamination can mask or mimic fetal genetic abnormalities, resulting in false‑negative or false‑positive diagnoses in prenatal screening, pre‑implantation genetic testing, and research studies.
  • Detection and mitigation:
    Laboratories use quantitative PCR, short tandem repeat (STR) profiling, or SNP‑based assays to quantify maternal DNA proportion and may repeat sampling or apply computational correction when MCC exceeds accepted thresholds.

Common Misconceptions

Myth

MCC only occurs in amniocentesis.

Fact

MCC can be found in any fetal sample, including chorionic villus sampling, fetal blood, and even cell‑free DNA from maternal plasma.

Myth

A small amount of maternal DNA never affects results.

Fact

Even low‑level contamination (as little as 5 % of total DNA) can bias quantitative assays, especially when detecting mosaicism or low‑frequency variants.

FAQ

How is maternal cell contamination identified in the lab?

Laboratories typically use short tandem repeat (STR) profiling, quantitative PCR of sex‑specific markers, or SNP‑based assays to compare maternal and fetal DNA ratios. A discrepancy indicating a significant maternal DNA proportion triggers an MCC flag.

Can maternal cell contamination be completely eliminated?

While strict collection protocols and careful processing can greatly reduce the risk, it is impossible to guarantee zero contamination. Therefore, detection and corrective measures are essential components of prenatal testing workflows.

Does MCC affect all types of prenatal tests equally?

MCC has the greatest impact on tests that rely on quantitative DNA measurements, such as karyotyping, microarray analysis, and next‑generation sequencing. Tests based on protein markers or imaging are not directly affected.

References

  1. Benn, P., & Hunkapiller, J. (2020). Maternal cell contamination in prenatal diagnostics. *Prenatal Diagnosis*, 40(3), 271‑280.
  2. Sullivan, K. et al. (2019). Quantitative PCR strategies for detecting maternal cell contamination. *Molecular Genetics & Genomic Medicine*, 7(5), e00745.
  3. van den Heuvel, M. et al. (2021). Impact of maternal cell contamination on next‑generation sequencing results. *Clinical Chemistry*, 67(12), 1659‑1667.
  4. American College of Medical Genetics and Genomics. (2022). Laboratory guidelines for managing maternal cell contamination. *ACMG Practice Guidelines*.
  5. Liu, X. & Wang, Y. (2023). Bioinformatic correction of maternal DNA in fetal whole‑genome sequencing. *Genome Medicine*, 15(1), 12.

Related Terms

Maternal Cell‑Free DNA
Fragments of fetal DNA circulating in the mother's plasma, used for non‑invasive prenatal testing.
Chorionic Villus Sampling
An invasive prenatal test that collects placental tissue to analyze fetal chromosomes.
Non‑invasive Prenatal Testing
Screening method that analyzes fetal DNA in maternal blood to assess chromosomal abnormalities.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *